Author:
Versluis M A,de Jong R A,Plat A,Bosse T,Smit V T,Mackay H,Powell M,Leary A,Mileshkin L,Kitchener H C,Crosbie E J,Edmondson R J,Creutzberg C L,Hollema H,Daemen T,de Bock G H,Nijman H W
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P, Vergote I (2005) Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol 98 (2): 274–280.
2. ASTEC study group,, Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, Eisenhauer E, Bacon M, Tu D, Parmar MK, Amos C, Murray C, Qian W (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373 (9658): 137–146.
3. Bijen CB, Bantema-Joppe EJ, de Jong RA, Leffers N, Mourits MJ, Eggink HF, van der Zee AG, Hollema H, de Bock GH, Nijman HW (2010) The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. Int J Cancer 126 (6): 1417–1427.
4. Bindea G, Mlecnik B, Fridman WH, Galon J (2011) The prognostic impact of anti-cancer immune response: a novel classification of cancer patients. Semin Immunopathol 33 (4): 335–340.
5. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15 (1): 10–17.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献